All
 |
Merrion Pharmaceuticals plc announces commencement of next stage of oral drug research collaboration programme with Novo Nordisk
Jul 18, 2008
|
20.3 KB |
| |
Dublin, Ireland Merrion Pharmaceuticals today announced the continuation of an oral drug delivery research collaboration programme with Novo Nordisk. This follows on from the completion of several oral feasibility studies combining Merrion's Gastrointestinal Permeation Enhancement Technology (GIPET) oral drug delivery technology with ...
|
| |
Merrion Pharmaceuticals Appoints Dr John Fox as Chief Development Officer
Jul 10, 2008
|
33.7 KB |
| |
Result of AGM
Jul 7, 2008
|
26.1 KB |
| |
Merrion Pharmaceuticals 2007 Annual Report
Jun 10, 2008
|
290.6 KB |
|
Merrion Pharmaceuticals plc appoints Paddy O'Sullivan to Board of Directors
May 21, 2008
|
22.6 KB |
| |
Released 21 May 2008...
|
| |
Merrion Pharmaceuticals plc announces 2007 year end financial results
Apr 24, 2008
|
106.7 KB |
|
Merrion Pharmaceuticals plc announce change to Board of Directors
Apr 17, 2008
|
19.0 KB |
| |
...
|
|
Merrion Pharmaceuticals plc press statement from Merger Market- Deal Drivers Seminar
Feb 21, 2008
|
21.4 KB |
| |
Released Feb 21, 2008...
|
|
Merrion Pharmaceuticals plc announce change to Board of Directors
Feb 14, 2008
|
23.1 KB |
| |
Released February 14th, 2008
Press Statement from Merrion Pharmaceuticals plc Dublin, Ireland and Wilmington, NC, Feb 14 2008 Merrion Pharmaceuticals plc, ("Merrion") an international specialty pharmaceutical company, today announced that Dr. Michael McKenna will assume the role of Chairman, with eff...
|
|
Merrion Pharmaceuticals to Present at UKICRS
Jan 22, 2008
|
22.3 KB |
| |
Released January 25th, 2008...
|
|
Merrion Pharmaceuticals Announces Lectureship Agreement with Trinity College Dublin
Jan 17, 2008
|
84.3 KB |
| |
Dublin, Ireland and Wilmington, NC, Jan 17 2008Merrion Pharmaceuticals plc, an international specialty pharmaceutical company, today announced a sponsorship agreement with Trinity College Dublin (The 'Merrion Lectureship') Under the agreement, Trinity have recruited a lecturer to the School of Pharmacy and Pharmaceutical Sci...
|
| |
Merrion Pharmaceuticals Plc Admitted to the IEX
Dec 18, 2007
|
19.5 KB |
| |
Merrion Pharma Schedule One Announcement Final
Dec 13, 2007
|
39.8 KB |
|
Merrion Pharma Conditional Trading Announcement Final
Dec 13, 2007
|
22.3 KB |
| |
This announcement is an advertisement and not a prospectus and has been prepared in connection with the Placing (the "Placing") of ordinary shares (the "Shares") of Merrion Pharmaceuticals plc ("Merrion Pharmaceuticals" or the "Company") and the admission of the Shares to IEX (the "Admission"). Investors should not subscribe for or purchase any Sha...
|
|
Merrion Announces Filing of F1 for Initial Public Offering in the United States
Apr 2, 2007
|
21.9 KB |
| |
Dublin, Ireland and Wilmington, NC, April 2
Merrion Pharmaceuticals Ltd today announced that it has filed a Registration Statement on Form F-1 with the US Securities & Exchange Commission in the United States relating to the proposed initial public offering of its ordinary shares in the form of American Depositary Shares and or...
|
|
Merrion Announces Positive Clinical Results for Osteoporosis Drug MER 103
Jan 16, 2007
|
23.4 KB |
| |
Dublin, Ireland and Wilmington, NC, January 16
Merrion Pharmaceuticals Ltd, an international specialty pharmaceutical company, today announced the successful completion of a clinical pharmacology study of MER 103, a novel oral formulation of alendronate sodium. MER 103 is an enteric-coated tablet of alendronate and GIPET(TM), Me...
|
|
Merrion Pharmaceuticals Complete €8million Funding Round
Nov 29, 2006
|
20.1 KB |
| |
29th November 2006
Merrion Pharmaceuticals Ltd, Dublin, announced the successful conclusion of an €8m funding round, which was oversubscribed, and was managed on behalf of the company by Goodbody Stockbrokers. Participation in this funding round was from previous investors in a €6m funding round conducted in April of this ye...
|
|
Merrion Pharmaceuticals announce Research Collaboration with Trinity College
Oct 20, 2006
|
22.2 KB |
| |
20th October 2006
Merion Pharmaceuticals today announced new research collaboration with Trinity College, Dublin. The research is expected to be conducted over several years by Trinity College Immunology researchers and focus on the area of oral vaccine. The research aims to establish key proofs of principle with regard to Me...
|
|
Merrion Pharmaceuticals announce collaboration with Hunter-Fleming
Jul 17, 2006
|
23.3 KB |
| |
Wilmington NC and Dublin Ireland, July 17, 2006
Merrion Pharmaceuticals today announced the commencement of an oral drug delivery research collaboration with Hunter-Fleming Ltd. This agreement combines Hunter-Fleming's HF0420 and Merrion's Gastrointestinal Permeation Enhancement Technology (GIPET) oral drug delivery technology...
|
|
Mr. Declan Ryan joins board of Merrion Pharmaceuticals Successful completion of interim funding
Jun 29, 2006
|
23.7 KB |
| |
Wilmington NC and Dublin Ireland, June 29, 2006
Merrion Pharmaceuticals confirmed today that Mr Declan Ryan of Irelandia Investments recently joined its Board of Directors.
Mr Ryan, was a director of Ryanair Holdings from 1996 to 2003, where he held several senior management positions, including CEO. He currently ...
|
|
|
